4//SEC Filing
MacLean Alexandra 4
Accession 0001104659-24-102836
CIK 0001644963other
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 4:55 PM ET
Size
5.4 KB
Accession
0001104659-24-102836
Insider Transaction Report
Form 4
MacLean Alexandra
Chief Executive Officer
Transactions
- Award
COMMON STOCK, PAR VALUE $0.0001
2024-09-23+170,000→ 170,000 total
Footnotes (1)
- [F1]Represents an award of 170,000 restricted stock units which will vest in equal installments at September 30, 2024, December 31, 2024, September 23, 2025, and September 23, 2026. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and Change in Control events (as defined in the Avenue Therapeutics, Inc. 2015 Incentive Plan); the amount will be distributed in the form of the Issuer's common stock.
Documents
Issuer
AVENUE THERAPEUTICS, INC.
CIK 0001644963
Entity typeother
Related Parties
1- filerCIK 0001940880
Filing Metadata
- Form type
- 4
- Filed
- Sep 24, 8:00 PM ET
- Accepted
- Sep 25, 4:55 PM ET
- Size
- 5.4 KB